|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cunningham D, Allum WH, Stenning SP,
Thompson JN, Van de Velde CJ, Nicolson M, Scarffe JH, Lofts FJ,
Falk SJ, Iveson TJ, et al: Perioperative chemotherapy versus
surgery alone for resectable gastroesophageal cancer. N Engl J Med.
355:11–20. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Liu C, Lu P, Lu Y, Xu H, Wang S and Chen
J: Clinical implications of metastatic lymph node ratio in gastric
cancer. BMC Cancer. 7:2002007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ohta K, Hoshino H, Wang J, Ono S, Iida Y,
Hata K, Huang SK, Colquhoun S and Hoon DS: MicroRNA-93 activates
c-Met/PI3K/Akt pathway activity in hepatocellular carcinoma by
directly inhibiting PTEN and CDKN1A. Oncotarget. 6:3211–3324. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cazzalini O, Scovassi AI, Savio M, Stivala
LA and Prosperi E: Multiple roles of the cell cycle inhibitor p21
(CDKN1A) in the DNA damage response. Mutat Res. 704:12–20. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Prives C and Gottifredi V: The p21 and
PCNA partnership: A new twist for an old plot. Cell Cycle.
7:3840–3846. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Andries V, Vandepoele K, Staes K, Berx G,
Bogaert P, Van Isterdael G, Ginneberge D, Parthoens E,
Vandenbussche J, Gevaert K, et al: NBPF1, a tumor suppressor
candidate in neuroblastoma, exerts growth inhibitory effects by
inducing a G1 cell cycle arrest. BMC Cancer. 15:3912015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Park C, Jeong NY, Kim GY, Han MH, Chung
IM, Kim WJ, Yoo YH and Choi YH: Momilactone B induces apoptosis and
G1 arrest of the cell cycle in human monocytic leukemia U937 cells
through downregulation of pRB phosphorylation and induction of the
cyclin-dependent kinase inhibitor p21Waf1/Cip1. Oncol Rep.
31:1653–1660. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wei CY, Tan QX, Zhu X, Qin QH, Zhu FB, Mo
QG and Yang WP: Expression of CDKN1A/p21 and TGFBR2 in breast
cancer and their prognostic significance. Int J Clin Exp Pathol.
8:14619–14629. 2015.PubMed/NCBI
|
|
10
|
Li S, Wang C, Yu X, Wu H, Hu J, Wang S and
Ye Z: miR-3619-5p inhibits prostate cancer cell growth by
activating CDKN1A expression. Oncol Rep. 37:241–248. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tang H, Wu Y, Liu M, Qin Y, Wang H, Wang
L, Li S, Zhu H, He Z, Luo J, et al: SEMA3B improves the survival of
patients with esophageal squamous cell carcinoma by upregulating
p53 and p21. Oncol Rep. 36:900–908. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang X, Lin Y, Lan F, Yu Y, Ouyang X, Wang
X, Huang Q, Wang L, Tan J and Zheng F: A GG allele of 3′-side AKT1
SNP is associated with decreased AKT1 activation and better
prognosis of gastric cancer. J Cancer Res Clin Oncol.
140:1399–1411. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yoo CH, Noh SH, Kim YI and Min JS:
Comparison of prognostic significance of nodal staging between old
(4th edition) and new (5th edition) UICC TNM classification for
gastric carcinoma. International union against cancer. World J
Surg. 23:492–497. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ward JH: NCCN Guidelines and the
International community. J Natl Compr Canc Netw. 9:133–134. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang X, Lin Y, Lan F, Yu Y, Ouyang X, Liu
W, Xie F, Wang X and Huang Q: BAX and CDKN1A polymorphisms
correlated with clinical outcomes of gastric cancer patients
treated with postoperative chemotherapy. Med Oncol. 31:2492014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kawata N, Tsuchiya N, Horikawa Y, Inoue T,
Tsuruta H, Maita S, Satoh S, Mitobe Y, Narita S and Habuchi T: Two
surviving polymorphisms are cooperatively associated with bladder
cancer susceptibility. Int J Cancer. 129:1872–1880. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Huang Q, Huang Q, Chen W, Wang L, Lin W,
Lin J and Lin X: Identification of transgelin as a potential novel
biomarker for gastric adenocarcinoma based on proteomics
technology. J Cancer Res Clin Oncol. 134:1219–1227. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Galeano F, Rossetti C, Tomaselli S,
Cifaldi L, Lezzerini M, Pezzullo M, Boldrini R, Massimi L, Di Rocco
CM, Locatelli F, et al: ADAR2-editing activity inhibits
glioblastoma growth through the modulation of the
CDC14B/Skp2/p21/p27 axis. Oncogene. 32:998–1009. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Morton JP, Jamieson NB, Karim SA, Athineos
D, Ridgway RA, Nixon C, McKay CJ, Carter R, Brunton VG, Frame MC,
et al: LKB1 haploinsufficiency cooperates with Kras to promote
pancreatic cancer through suppression of p21-dependent growth
arrest. Gastroenterology. 139:586–597. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Brown SG, Knowell AE, Hunt A, Patel D,
Bhosle S and Chaudhary J: Interferon inducible antiviral MxA is
inversely associated with prostate cancer and regulates cell cycle,
invasion and Docetaxel induced apoptosis. Prostate. 75:266–279.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Koh DI, Han D, Ryu H, Choi WI, Jeon BN,
Kim MK, Kim Y, Kim JY, Parry L, Clarke AR, et al: KAISO, a critical
regulator of p53-mediated transcription of CDKN1A and apoptotic
genes. Proc Natl Acad Sci USA. 111:pp. 15078–15083. 2014,
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sun Y, Yang S, Sun N and Chen J:
Differential expression of STAT1 and p21 proteins predicts
pancreatic cancer progression and prognosis. Pancreas. 43:619–623.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Belt EJ, Brosens RP, Delis-van Diemen PM,
Bril H, Tijssen M, van Essen DF, Heymans MW, Beliën JA, Stockmann
HB, Meijer S, et al: Cell cycle proteins predict recurrence in
stage II and III colon cancer. Ann Surg Oncol. 19 Suppl
3:S682–S692. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mitomi H, Ohkura Y, Fukui N, Kanazawa H,
Kishimoto I, Nakamura T, Yokoyama K, Sada M, Kobayashi K, Tanabe S,
et al: P21WAF1/CIP1 expression in colorectal carcinomas is related
to Kras mutations and prognosis. Eur J Gastroenterol Hepatol.
19:883–889. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wu DW, Liu WS, Wang J, Chen CY, Cheng YW
and Lee H: Reduced p21 (WAF1/CIP1) via alteration of p53-DDX3
pathway is associated with poor relapse-free survival in
early-stage human papillomavirus-associated lung cancer. Clin
Cancer Res. 17:1895–1905. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Young TW, Rosen DG, Mei FC, Li N, Liu J,
Wang XF and Cheng X: Up-regulation of tumor susceptibility gene 101
conveys poor prognosis through suppression of p21 expression in
ovarian cancer. Clin Cancer Res. 13:3848–3854. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Buchynska LG, Nesina IP, Yurchenko NP,
Bilyk OO, Grinkevych VN and Svintitsky VS: Expression of p53,
p21WAF1/CIP1, p16INK4A and Ki-67 proteins in serous ovarian tumors.
Exp Oncol. 29:49–53. 2007.PubMed/NCBI
|
|
28
|
Khalili M, Vasei M, Khalili D,
Alimoghaddam K, Sadeghizadeh M and Mowla SJ: Downregulation of the
genes involved in reprogramming (SOX2, c-MYC, miR-302, miR-145, and
P21) in gastric adenocarcinoma. J Gastrointest Cancer. 46:251–258.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Dai M, Al-Odaini AA, Arakelian A, Rabbani
SA, Ali S and Lebrun JJ: A novel function for p21Cip1 and
acetyltransferase p/CAF as critical transcriptional regulators of
TGF β-mediated breast cancer cell migration and invasion. Breast
Cancer Res. 14:R1272012. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang H, Zhang X, Ji S, Hao C, Mu Y, Sun J
and Hao J: Sohlh2 inhibits ovarian cancer cell proliferation by
upregulation of p21 and downregulation of cyclin D1.
Carcinogenesis. 35:1863–1871. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu J, Hu Y, Hu W, Xie X, Bella Ela A, Fu
J and Rao D: Expression and prognostic relevance of p21WAF1 in
stage III esophageal squamous cell carcinoma. Dis Esophagus.
25:67–71. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Watanabe M, Nakahata S, Hamasaki M, Saito
Y, Kawano Y, Hidaka T, Yamashita K, Umeki K, Taki T, Taniwaki M, et
al: Downregulation of CDKN1A in adult T-cell leukemia/lymphoma
despite overexpression of CDKN1A in human T-lymphotropic virus
1-infected cell lines. J Virol. 84:6966–6977. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Nie FQ, Sun M, Yang JS, Xie M, Xu TP, Xia
R, Liu YW, Liu XH, Zhang EB, Lu KH, et al: Long noncoding RNA ANRIL
promotes non-small cell lung cancer cell proliferation and inhibits
apoptosis by silencing KLF2 and P21 expression. Mol Cancer Ther.
14:268–277. 2015. View Article : Google Scholar : PubMed/NCBI
|
